A Case Report on Management and Treatment of a Male Patient Suffering from Interstitial Lung Disease (ILD) or Pulmonary Disease

The present study is a case report of a man who was initially diagnosed with “interstitial lung disease” (ILD) or pulmonary disease which is supposed to be an umbrella term for a large group of disorders responsible for scattered fibrosis of the lungs. It is an irreversible scenario. The causative factors for the above mentioned diseased conditions are yet to be found, and all of them are grouped under interstitial pneumonias. The patient underwent detailed clinical investigations on several parameters such as CT pulmonary angiography, Lower limb venous Doppler, D-dimer test, Real Time polymerase chain reaction (RT PCR) for the novel SARS-CoV -2, Ultra-sonography (USG) of the abdomen, C-reactive proteins (CRP), complete blood count (CBC), Legionella antigen test, specific Mycoplasma IgM antibody assay, the total parameters of the renal functioning test of the blood serum, pro-calcitonin (PCT) level, and the acute coronary syndrome panel (POCT). After detailed investigations the patient was diagnosed with ILD and medications specific to the disease was prescribed. The medications that were prescribed were ceftriaxone with injection pantoprazole, paracetamol, levofloxacin, enoxaparin, amiodiprine, and furosemide. He was also advised to continue his own other medications along with these and contact at the emergency services of the hospital in case of any urgency. He was also advised for follow up visit. The patient responded to the applied therapeutic interventions and survived from the suffering. Thus, here a detailed case reporting has been conducted with the particular disease along with its diagnosis and management.